This cancer cell sensitivity to Gmnn loss may involve greater relative ability of non-cancer cell lines to use alternate molecular mechanisms to control Cdt1 activity by proteolysis, and/or relative over-expression of Cdt1 and pre-RC proteins in many cancer cell contexts [10, 11]. Here, CDT1 is linked to cancer.